Trial to start for new heart attack drug
A potential new drug to improve the long-term outcomes for heart attack patients will be…
November 23, 2022 - 3 minutes
France
Osivax is designing future-proof influenza and Covid vaccines
Viruses causing influenza and COVID-19 continually evolve to escape our vaccine protections. The French firm…
November 21, 2022 - 5 minutes
Aelis Farma’s first trial for cognitive disorder drug for Down Syndrome patients
Aelis Farma has announced positive results from its safety trials in healthy volunteers and the…
November 15, 2022 - 4 minutes
Bel Group and Standing Ovation partner on cheese proteins
Dairy giant Bel Group and start-up Standing Ovation are partnering on incorporating casein milk protein…
November 15, 2022 - 2 minutes
First patient dosed in Nouscom colorectal cancer study
Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized immunotherapies, says the first patient…
November 15, 2022 - 3 minutes
BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS
3P BioPharmaceuticals and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat…
November 15, 2022 - 2 minutes
MaaT Pharma: leading the charge in microbiome therapeutics
The first generation of microbiome therapeutics is hitting its first approvals. Savita Bernal, chief business…
November 14, 2022 - 5 minutes
33 Californie launches new fund for healthcare startups
33 Californie, an investment fund specialized in the healthcare sector, has opened subscriptions for CaLySeed,…
November 14, 2022 - 3 minutes
Get to know 15 of the best biotech companies in Paris
Paris may attract tourist masses, but it also attracts a lot of biotech enthusiasts. In…
November 4, 2022 - 11 minutes
Beyond Biotech podcast 21: CanSinoBIO, HTID, Longevity Science Foundation
This week, we have three interviews, and four guests. We chat with Pierre Corneille VP…
November 4, 2022 - 2 minutes
Servier and OSE Immunotherapeutics complete enrollment in Sjögren’s syndrome trial
Servier and French biotech company OSE Immunotherapeutics SA have completed patient enrollment in a phase…
November 3, 2022 - 2 minutes
Meletios Therapeutics wins €5.2M European Commission funding for SARS research
Meletios Therapeutics, a French biotech company, announced today (November 2) that it has been named…
November 2, 2022 - 3 minutes
